Current HIV treatment guidelines - An overview

R. Chris Rathbun, S. M. Lockhart, R. J. Stephens

Research output: Contribution to journalReview article

48 Citations (Scopus)

Abstract

Use of highly active antiretroviral therapy has resulted in significant reductions in HIV-related morbidity and mortality. Current therapeutic approaches target cellular entry, viral transcription, and maturation of newly formed virus. Combination therapy is necessary to provide durable suppression of viral replication and immune reconstitution. A variety of consensus treatment guidelines addressing prophylaxis and treatment of HIV infection and opportunistic infections have been developed to serve as resources for clinicians. A summary of U.S. Department of Health and Human Services Guidelines for Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents and International AIDS Society-USA Panel recommendations for Treatment of Adult HIV infection are presented. Considerations for selection of antiretroviral therapy in special populations (e.g., pregnancy, coinfection with tuberculosis, hepatitis B and C virus) are highlighted. U.S. Public Health Service guidelines for management of occupational exposure to HIV and initiation of postexposure prophylaxis are discussed as well as World Health Organization recommendations for use of antiretroviral therapy in resource-limited settings. The pathophysiology of HIV infection, viral load testing methods, viral dynamics, and classification of antiretrovirals are also briefly reviewed.

Original languageEnglish
Pages (from-to)1045-1063
Number of pages19
JournalCurrent Pharmaceutical Design
Volume12
Issue number9
DOIs
StatePublished - 1 Mar 2006

Fingerprint

HIV
Guidelines
HIV Infections
Therapeutics
United States Dept. of Health and Human Services
Anti-Retroviral Agents
United States Public Health Service
Opportunistic Infections
Highly Active Antiretroviral Therapy
Occupational Exposure
Viral Load
Coinfection
Hepatitis B virus
Hepacivirus
HIV-1
Tuberculosis
Viruses
Morbidity
Pregnancy
Mortality

Keywords

  • Antiretroviral therapy
  • HIV infection
  • Treatment guidelines

Cite this

Rathbun, R. Chris ; Lockhart, S. M. ; Stephens, R. J. / Current HIV treatment guidelines - An overview. In: Current Pharmaceutical Design. 2006 ; Vol. 12, No. 9. pp. 1045-1063.
@article{a2767cccd61a4d2caf8b73ae3b90e301,
title = "Current HIV treatment guidelines - An overview",
abstract = "Use of highly active antiretroviral therapy has resulted in significant reductions in HIV-related morbidity and mortality. Current therapeutic approaches target cellular entry, viral transcription, and maturation of newly formed virus. Combination therapy is necessary to provide durable suppression of viral replication and immune reconstitution. A variety of consensus treatment guidelines addressing prophylaxis and treatment of HIV infection and opportunistic infections have been developed to serve as resources for clinicians. A summary of U.S. Department of Health and Human Services Guidelines for Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents and International AIDS Society-USA Panel recommendations for Treatment of Adult HIV infection are presented. Considerations for selection of antiretroviral therapy in special populations (e.g., pregnancy, coinfection with tuberculosis, hepatitis B and C virus) are highlighted. U.S. Public Health Service guidelines for management of occupational exposure to HIV and initiation of postexposure prophylaxis are discussed as well as World Health Organization recommendations for use of antiretroviral therapy in resource-limited settings. The pathophysiology of HIV infection, viral load testing methods, viral dynamics, and classification of antiretrovirals are also briefly reviewed.",
keywords = "Antiretroviral therapy, HIV infection, Treatment guidelines",
author = "Rathbun, {R. Chris} and Lockhart, {S. M.} and Stephens, {R. J.}",
year = "2006",
month = "3",
day = "1",
doi = "10.2174/138161206776055840",
language = "English",
volume = "12",
pages = "1045--1063",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "9",

}

Current HIV treatment guidelines - An overview. / Rathbun, R. Chris; Lockhart, S. M.; Stephens, R. J.

In: Current Pharmaceutical Design, Vol. 12, No. 9, 01.03.2006, p. 1045-1063.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Current HIV treatment guidelines - An overview

AU - Rathbun, R. Chris

AU - Lockhart, S. M.

AU - Stephens, R. J.

PY - 2006/3/1

Y1 - 2006/3/1

N2 - Use of highly active antiretroviral therapy has resulted in significant reductions in HIV-related morbidity and mortality. Current therapeutic approaches target cellular entry, viral transcription, and maturation of newly formed virus. Combination therapy is necessary to provide durable suppression of viral replication and immune reconstitution. A variety of consensus treatment guidelines addressing prophylaxis and treatment of HIV infection and opportunistic infections have been developed to serve as resources for clinicians. A summary of U.S. Department of Health and Human Services Guidelines for Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents and International AIDS Society-USA Panel recommendations for Treatment of Adult HIV infection are presented. Considerations for selection of antiretroviral therapy in special populations (e.g., pregnancy, coinfection with tuberculosis, hepatitis B and C virus) are highlighted. U.S. Public Health Service guidelines for management of occupational exposure to HIV and initiation of postexposure prophylaxis are discussed as well as World Health Organization recommendations for use of antiretroviral therapy in resource-limited settings. The pathophysiology of HIV infection, viral load testing methods, viral dynamics, and classification of antiretrovirals are also briefly reviewed.

AB - Use of highly active antiretroviral therapy has resulted in significant reductions in HIV-related morbidity and mortality. Current therapeutic approaches target cellular entry, viral transcription, and maturation of newly formed virus. Combination therapy is necessary to provide durable suppression of viral replication and immune reconstitution. A variety of consensus treatment guidelines addressing prophylaxis and treatment of HIV infection and opportunistic infections have been developed to serve as resources for clinicians. A summary of U.S. Department of Health and Human Services Guidelines for Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents and International AIDS Society-USA Panel recommendations for Treatment of Adult HIV infection are presented. Considerations for selection of antiretroviral therapy in special populations (e.g., pregnancy, coinfection with tuberculosis, hepatitis B and C virus) are highlighted. U.S. Public Health Service guidelines for management of occupational exposure to HIV and initiation of postexposure prophylaxis are discussed as well as World Health Organization recommendations for use of antiretroviral therapy in resource-limited settings. The pathophysiology of HIV infection, viral load testing methods, viral dynamics, and classification of antiretrovirals are also briefly reviewed.

KW - Antiretroviral therapy

KW - HIV infection

KW - Treatment guidelines

UR - http://www.scopus.com/inward/record.url?scp=33645564927&partnerID=8YFLogxK

U2 - 10.2174/138161206776055840

DO - 10.2174/138161206776055840

M3 - Review article

C2 - 16515485

AN - SCOPUS:33645564927

VL - 12

SP - 1045

EP - 1063

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 9

ER -